UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. today reported financial results for its third quarter ended September 30, 2009. As previously reported on September 21, 2009, Questcor's financial results were negatively affected by the combination of a lower number of shipped and paid prescriptions for the treatment of infantile spasms and unusually high amounts of Medicaid rebates related ...

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News